[
    [
        {
            "time": "",
            "original_text": "试水疫苗流通、血液制品先后受挫，独家疫苗将成为沃森生物新“引擎”？",
            "features": {
                "keywords": [
                    "疫苗",
                    "血液制品",
                    "沃森生物",
                    "独家疫苗"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "试水疫苗流通、血液制品先后受挫，独家疫苗将成为沃森生物新“引擎”？",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "沃森生物董事长又信批违规了？被指两年前约定转让4000万股没披露 金融监管处罚",
            "features": {
                "keywords": [
                    "沃森生物",
                    "董事长",
                    "信批违规",
                    "股权转让",
                    "金融监管"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物董事长又信批违规了？被指两年前约定转让4000万股没披露 金融监管处罚",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 10,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "生物医药行业动态跟踪报告:疫苗批签发跟踪,月度批签发数据持续回暖",
            "features": {
                "keywords": [
                    "生物医药",
                    "疫苗",
                    "批签发",
                    "月度数据",
                    "回暖"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "生物医药行业动态跟踪报告:疫苗批签发跟踪,月度批签发数据持续回暖",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        }
    ]
]